Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation
<h4>Aim</h4> Data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in relation to the risk of cardiovascular (CV) disease and renal protection among patients with atrial fibrillation (AF), are relatively sparse. We aimed to compare the effectiveness and safety of NOACs...
| Autors principals: | , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Public Library of Science (PLoS)
2022-01-01
|
| Col·lecció: | PLoS ONE |
| Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560050/?tool=EBI |